v3.20.1
CONSOLIDATED INCOME STATEMENT - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenue $ 17,571 $ 18,182
Cost 9,649 10,139
Gross profit 7,922 8,043
Expense and other (income):    
Selling, general and administrative 5,955 4,691
Research, development and engineering 1,625 1,433
Intellectual property and custom development income (116) (101)
Other (income) and expense 182 (73)
Interest expense 326 210
Total expense and other (income) 7,972 6,160
Income/(loss) from continuing operations before income taxes (49) 1,883
Provision for/(benefit from) income taxes (1,226) 289
Income from continuing operations 1,176 1,593
Income/(loss) from discontinued operations, net of tax (1) (2)
Net income $ 1,175 $ 1,591
Assuming dilution:    
Continuing operations (in dollars per share) $ 1.31 $ 1.78
Discontinued operations (in dollars per share) 0.00 0.00
Total (in dollars per share) 1.31 1.78
Basic:    
Continuing operations (in dollars per share) 1.32 1.79
Discontinued operations (in dollars per share) 0.00 0.00
Total (in dollars per share) $ 1.32 $ 1.79
Weighted-average number of common shares outstanding:    
Assuming dilution (in shares) 895,039,238 893,910,526
Basic (in shares) 887,969,345 889,581,542
Services    
Revenue [1] $ 11,373 $ 11,915
Cost [1] 7,843 8,272
Sales    
Revenue [1] 5,895 5,862
Cost [1] 1,624 1,603
Financing    
Revenue 302 404
Cost $ 181 $ 264
[1] Reclassified to conform to current period presentation. Refer to note 1, “Basis of Presentation,” for additional information.